Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

James Aronson to Osteogenesis, Distraction

This is a "connection" page, showing publications James Aronson has written about Osteogenesis, Distraction.

 
Connection Strength
  
 
 
1.337
  
  1. Aronson J. Modulation of distraction osteogenesis in the aged rat by fibroblast growth factor. Clin Orthop Relat Res. 2004 Aug; (425):264-83.
    View in: PubMed
    Score: 0.232
  2. Aronson J, Shin HD. Imaging techniques for bone regenerate analysis during distraction osteogenesis. J Pediatr Orthop. 2003 Jul-Aug; 23(4):550-60.
    View in: PubMed
    Score: 0.216
  3. Stine KC, Wahl EC, Liu L, Skinner RA, Vanderschilden J, Bunn RC, Montgomery CO, Suva LJ, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Lumpkin CK. Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop Res. 2014 Mar; 32(3):464-70.
    View in: PubMed
    Score: 0.111
  4. Liu L, Aronson J, Lecka-Czernik B. Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration. Bone. 2013 Jan; 52(1):247-58.
    View in: PubMed
    Score: 0.103
  5. Wahl EC, Aronson J, Liu L, Skinner RA, Ronis MJ, Lumpkin CK. Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure. Alcohol. 2012 Mar; 46(2):133-8.
    View in: PubMed
    Score: 0.095
  6. Perrien DS, Nicks KM, Liu L, Akel NS, Bacon AW, Skinner RA, Swain FL, Aronson J, Suva LJ, Gaddy D. Inhibin A enhances bone formation during distraction osteogenesis. J Orthop Res. 2012 Feb; 30(2):288-95.
    View in: PubMed
    Score: 0.094
  7. Wahl EC, Aronson J, Liu L, Skinner RA, Miller MJ, Cockrell GE, Fowlkes JL, Thrailkill KM, Bunn RC, Ronis MJ, Lumpkin CK. Direct bone formation during distraction osteogenesis does not require TNFalpha receptors and elevated serum TNFalpha fails to inhibit bone formation in TNFR1 deficient mice. Bone. 2010 Feb; 46(2):410-7.
    View in: PubMed
    Score: 0.083
  8. Wahl EC, Aronson J, Liu L, Liu Z, Perrien DS, Skinner RA, Badger TM, Ronis MJ, Lumpkin CK. Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol. 2007 May 01; 220(3):302-10.
    View in: PubMed
    Score: 0.069
  9. Wahl EC, Liu L, Perrien DS, Aronson J, Hogue WR, Skinner RA, Hidestrand M, Ronis MJ, Badger TM, Lumpkin CK. A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation. Alcohol. 2006 Jul; 39(3):159-67.
    View in: PubMed
    Score: 0.068
  10. Wahl EC, Perrien DS, Aronson J, Liu Z, Fletcher TW, Skinner RA, Feige U, Suva LJ, Badger TM, Lumpkin CK. Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis. Alcohol Clin Exp Res. 2005 Aug; 29(8):1466-72.
    View in: PubMed
    Score: 0.062
  11. Perrien DS, Liu Z, Wahl EC, Bunn RC, Skinner RA, Aronson J, Fowlkes J, Badger TM, Lumpkin CK. Chronic ethanol exposure is associated with a local increase in TNF-alpha and decreased proliferation in the rat distraction gap. Cytokine. 2003 Sep 21; 23(6):179-89.
    View in: PubMed
    Score: 0.055
  12. Perrien DS, Brown EC, Fletcher TW, Irby DJ, Aronson J, Gao GG, Skinner RA, Hogue WR, Feige U, Suva LJ, Ronis MJ, Badger TM, Lumpkin CK. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. J Pharmacol Exp Ther. 2002 Dec; 303(3):904-8.
    View in: PubMed
    Score: 0.052
  13. Perrien DS, Brown EC, Aronson J, Skinner RA, Montague DC, Badger TM, Lumpkin CK. Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem. 2002 Apr; 50(4):567-74.
    View in: PubMed
    Score: 0.049
  14. Stine KC, Wahl EC, Liu L, Skinner RA, VanderSchilden J, Bunn RC, Montgomery CO, Aronson J, Becton DL, Nicholas RW, Swearingen CJ, Suva LJ, Lumpkin CK. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. J Orthop Res. 2016 10; 34(10):1716-1724.
    View in: PubMed
    Score: 0.032
  15. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, Carver AA, Fowlkes JL, Aronson J, Lumpkin CK. Bone formation is impaired in a model of type 1 diabetes. Diabetes. 2005 Oct; 54(10):2875-81.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.